-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO ANNOUNCES INITIATION DATE OF PHASE II CLINICAL TRIAL OF AL001 FOR TREATMENT OF ALZHEIMER’S DISEASE TO TAKE PLACE AT MASSACHUSETTS GENERAL HOSPITAL

Reuters·03/25/2025 12:01:23

Please log in to view news